ARCHIVES

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Concepts for More Chemoprevention Projects, NEW RFAs for PV, Anti-Sense RNA Studies

October 31, 1986

Fund Squeeze Results In Percentage reductions for Renewed Program Project, Center Core Grants

April 8, 1977

NCI Advisory Group, Other Cancer Meetings

January 30, 1976

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

With Flashing Lights, Heckling, and Folk Song, Avastin Sets New Tone for FDA Debates

July 1, 2011

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012